Latest Urology News
Most patients have unrealistic survival expectations, which may compromise their ability to make informed treatment decisions.
Patients with a relatively low tumor risk and good general health status appear to experience the best survival.
Atezolizumab received accelerated FDA approval for patients whose disease has progressed despite platinum-based chemotherapy.
In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.
High rates of screening for individuals with limited long-term life expectancy for all tools.
The 15-hour surgery took place in early May.
Agency is recommending that health care providers not prescribe them for certain patients.
Multiple studies suggest they might.
In second study, exercise also found to improve nocturia.
Researchers found an adjusted 68% decreased risk of prostate cancer in men with IBD who used aminosalicylate.
Randomized clinical trials are often considered the highest level on which medical care should be based.
Mechanism may explain prostate cancer treatment resistance among African-American men.
Researchers believe arsenic exposure might contribute to higher-than-normal rates.
The PLCO trial's conclusion that routine PSA testing does not affect prostate cancer mortality risk could be wrong.
Findings support the use of a 5 grade-group system that more accurately reflects patient risk of adverse outcomes.
The odds of PSA screening were higher among blacks than non-Hispanic whites.
Researchers observe no significant survival difference for stage IIb patients.
PCNL procedure rate nearly doubles over a 2-decade period, study finds.
The timing of office visits and telephone calls helped identify a patient at risk for readmission post-radical cystectomy.
Most emergency department visits and readmissions after ureteroscopy are due to complaints of pain.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)